Nom du produit:2-(Difluoromethoxy)-7-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxaline

IUPAC Name:2-(difluoromethoxy)-7-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxaline

CAS:2073844-31-0
Formule moléculaire:C16H19BF2N2O3
Pureté:95%+
Numéro de catalogue:CM1050261
Poids moléculaire:336.15

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2073844-31-0
Formule moléculaire:C16H19BF2N2O3
Point de fusion:-
Code SMILES:FC(F)OC1=NC2C(N=C1)=C(C=C(C)C=2)B3OC(C)(C)C(C)(C)O3
Densité:
Numéro de catalogue:CM1050261
Poids moléculaire:336.15
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Related Products